For Biopharma

Education & events

News & Updates

Poster - 20 October 2024

Receptor occupancy assay development challenges for rare targets of bispecific drugs

Poster - 28 July 2024

Analytical performance of the plasma β-Amyloid 1-40 and 1-42 assays on the Fujirebio® LUMIPULSE® G1200 to support Alzheimer’s Disease clinical trials

Info Sheet - 16 July 2024

Global Trial Connect Brochure

Poster - 19 May 2024

Formulation development and characterization of a Marburg self-amplifying mRNA-lipid nanoparticle vaccine with toll-like receptor-7 agonists

Recent

Posters and publications

Poster - 17 November 2024

Retrospective analysis of nonclinical regulatory strategy for 13 approved oncology antibody-drug conjugates

Poster - 17 November 2024

Evaluation of endogenous and ex vivo stimulated matrices for validation of cytokine expression assessment

Poster - 17 November 2024

A 29-day two-dose and 3-day one-dose research and development study of intrathecal injection or epidural infusion in rats

Poster - 17 November 2024

Comparison of intratracheal and inhaled AAV pulmonary deposition in two species

Poster - 17 November 2024

Inhaled delivery of a selective immune modulator to minipigs produces favorable toxicity profile

Upcoming

Conferences & events

20-22 Nov 2024

EBF Open Symposium 2024

Visit conference site

19-23 Nov 2024

AMP Annual Meeting & Expo (Association for Molecular Pathology)

Visit conference site

Recorded

Videos & Webinars

Webinar - 15 May 2024

Overcoming key challenges in global cell and gene therapy trials with Labcorp

Video - 25 April 2024

From Lab to Life: Unraveling the mysteries of nonclinical ADME and human AME (Insights for optimizing your hAME)

Video - 8 April 2024

Challenges and opportunities for bioanalytical support of new drug modalities

Trending

Scientific Topics

Info Sheet - 23 July 2024

Labcorp Bioanalytical Services Antibody Drug-Conjugate (ADC) Services

Info Sheet - 23 July 2024

Antibody drug-conjugates (ADCs): Analytical considerations for QC release, stability testing, characterization and comparability

Article - 14 May 2024

Bioanalytical methods, strategies and outlook for antibody-drug conjugate trials (Chinese)

Info Sheet - 2 May 2024

Labcorp Biopharma Laboratory Services: Antibody-drug conjugate (ADC) capabilities

Article - 8 April 2024

Navigating complexities in ADC development with specialized global laboratory support and scientific expertise

Article - 8 April 2024

Bioanalytical methods, strategies and outlook for antibody-drug conjugate trials

Article - 7 December 2023

OmniSeq INSIGHT: Using immune profiling to stratify head and neck cancer subjects in an immunotherapy clinical trial

Article - 6 December 2023

Antibody Reagent Spotlight – Generating positive control antibodies for your Anti-Drug Antibody (ADA) assay

Article - 28 September 2023

Cell therapy for treatment of cancer

健康管理

疾患 & 治療領域

治療モダリティ＆方法

科学ラボ分野

ラボ関連

業界

Education & events

Receptor occupancy assay development challenges for rare targets of bispecific drugs

Analytical performance of the plasma β-Amyloid 1-40 and 1-42 assays on the Fujirebio® LUMIPULSE® G1200 to support Alzheimer’s Disease clinical trials

Global Trial Connect Brochure

Formulation development and characterization of a Marburg self-amplifying mRNA-lipid nanoparticle vaccine with toll-like receptor-7 agonists

Posters and publications

Retrospective analysis of nonclinical regulatory strategy for 13 approved oncology antibody-drug conjugates

Evaluation of endogenous and ex vivo stimulated matrices for validation of cytokine expression assessment

A 29-day two-dose and 3-day one-dose research and development study of intrathecal injection or epidural infusion in rats

Comparison of intratracheal and inhaled AAV pulmonary deposition in two species

Inhaled delivery of a selective immune modulator to minipigs produces favorable toxicity profile

Conferences & events

EBF Open Symposium 2024

AMP Annual Meeting & Expo (Association for Molecular Pathology)

Videos & Webinars

Overcoming key challenges in global cell and gene therapy trials with Labcorp

From Lab to Life: Unraveling the mysteries of nonclinical ADME and human AME (Insights for optimizing your hAME)

Challenges and opportunities for bioanalytical support of new drug modalities

Scientific Topics

Labcorp Bioanalytical Services Antibody Drug-Conjugate (ADC) Services

Antibody drug-conjugates (ADCs): Analytical considerations for QC release, stability testing, characterization and comparability

Bioanalytical methods, strategies and outlook for antibody-drug conjugate trials (Chinese)

Labcorp Biopharma Laboratory Services: Antibody-drug conjugate (ADC) capabilities

Navigating complexities in ADC development with specialized global laboratory support and scientific expertise

Bioanalytical methods, strategies and outlook for antibody-drug conjugate trials

OmniSeq INSIGHT: Using immune profiling to stratify head and neck cancer subjects in an immunotherapy clinical trial

Antibody Reagent Spotlight – Generating positive control antibodies for your Anti-Drug Antibody (ADA) assay

Cell therapy for treatment of cancer